February 09, 2026 a 01:00 pm
PODD: Fundamental Ratio Analysis - Insulet Corporation
Insulet Corporation, with its innovative Omnipod System, has positioned itself within the medical devices industry to serve insulin-dependent diabetes patients. However, its overall fundamental ratings suggest room for improvement in certain financial areas. Investors should weigh both the potential of the healthcare sector and the company's current market position strengths.
Fundamental Rating
Insulet Corporation holds a decent overall fundamental rating but faces challenges based on key financial metrics.
| Rating Category | Score | |
|---|---|---|
| Overall Rating | C+ | |
| Discounted Cash Flow | 1 | |
| Return on Equity | 4 | |
| Return on Assets | 4 | |
| Debt to Equity | 1 | |
| Price to Earnings | 1 | |
| Price to Book | 1 |
Historical Rating
Historical financial scores of Insulet Corporation demonstrate their journey towards achieving present scores.
| Date | Overall | DCF | ROE | ROA | Debt to Equity | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2026-02-06 | 2 | 1 | 4 | 4 | 1 | 1 | 1 |
| Previous | 0 | 1 | 4 | 4 | 1 | 1 | 1 |
Analyst Price Targets
Analyst consensus indicates a favorable outlook for Insulet Corporation's stock price.
| High | Low | Median | Consensus |
|---|---|---|---|
| $450 | $274 | $380 | $376.27 |
Analyst Sentiment
Analysts maintain a 'Buy' consensus for Insulet Corporation, influenced by numerous positive evaluations.
| Recommendation | Count | |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 33 | |
| Hold | 10 | |
| Sell | 3 | |
| Strong Sell | 0 |
Conclusion
Insulet Corporation offers innovation in the medical device sector, promising growth potential due to its Omnipod System. Nevertheless, investors should consider its current financial standings, especially its valuation metrics, before investment. The analyst sentiment is optimistic with a predominant 'Buy' rating, suggesting future growth in stock price. However, careful attention is required towards the company’s capacity to improve its financial fundamentals in the long term. Risks inherent in the healthcare industry and market competition are notable considerations.